Biblio Discovery — Demo Discovery Service

4 results for "An-Lin Li"

Showing 1–4 · 0.13 seconds · RSS

  1. Journal Article Full text

    Design and Manufacturing of a Passive Pressure Sensor Based on LC Resonance

    Cheng Zheng; Wei Li; An-Lin Li et al.

    Micromachines, Vol. 7 No. 5 · 2016 · English · DOAJ Scopus

    The LC resonator-based passive pressure sensor attracts much attention because it does not need a power source or lead wires between the sensing element and the readout system. This paper presents the design and manufacturing of a passive pressure sensor that contains a variable capacitor and a…

  2. Journal Article Full text

    Advances in crop phenotyping and multi-environment trials

    Zhe LIU,Fan ZHANG,Qin MA,Dong AN,Lin LI,Xiaodong ZHANG,Dehai ZHU,Shaoming LI

    Frontiers of Agricultural Science and Engineering, Vol. 2 No. 1 · 2015 · English · DOAJ

    Efficient evaluation of crop phenotypes is a prerequisite for breeding, cultivar adoption, genomics and phenomics study. Plant genotyping is developing rapidly through the use of high-throughput sequencing techniques, while plant phenotyping has lagged far behind and it has become the rate-limiting…

  3. Journal Article

    Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study)

    Hai-Yu Zhou; Shao-Peng Zheng; An-Lin Li et al.

    EClinicalMedicine, Vol. 24 · 2020 · English · DOAJ Scopus

    Background: The efficacy and safety of neoadjuvant treatment over surgery alone and that of neoadjuvant chemoradiotherapy (NCRT) over neoadjuvant chemotherapy (NCT) in resectable esophageal carcinoma remains inconclusive. This study (NewEC) used global data to comprehensively evaluate these…

  4. Journal Article

    EGFR activation disrupts immunotherapy response via SHP2-mediated suppression of tumor-intrinsic response to IFN-γ

    Wei-Tao Zhuang; Lan-Lan Pang; Li-Yang Hu et al.

    The Journal of Clinical Investigation, Vol. 136 No. 5 · 2026 · English · DOAJ Scopus

    Epidermal growth factor receptor–activating (EGFR-activating) mutations are established biomarkers of resistance to immune checkpoint blockade (ICB) in lung cancer, yet the precise molecular mechanism and effective therapeutic strategies remain elusive. In this study, we show that EGFR…